Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure

Overview of attention for article published in JAMA: Journal of the American Medical Association, December 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 64 news outlets
blogs: 3 blogs
twitter: 187 X users

facebook: 1 Facebook page
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 218 X posts from 187 X users, with an upper bound of 2,386,326 followers.

10/ ARIES-HM3: Aspirin vs. placebo in LVAD patients on VKA: skipping aspirin reduced bleeding without increasing thromboembolic risk. A paradigm shift? 🩸 🔗 https://t.co/5aZBeU744Q

Aspirin and Hemocompatibility Events With an LVAD in Advanced Heart Failure https://t.co/OksNX0PT17

RT @netuka_ivan: Proud to contribute with my IKEM team to outstanding ARIES Trial results which bring a practice change in LVADs realm! Rea…

RT @giovannilandoni: @JAMA_current @tscquizzato @YukiKotani5 @SRAnesthesiaICU @GiacomoMonti @critconcepts @emily_fri @doctorasadkhan @Fatig…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 214 additional X posts.